KADAR b-hCG PENDERITA MOLA HIDATIDOSA SEBELUM DAN SESUDAH KURETASE

Abstract

Hydatiform mole is an important disease, with a high incidence, many risk factors, and equity spreading. To know and compare
b-hCG levels among patients with hydatiform mole before and after curretage was investigated. A retrospective study from January
2002 to December 2005 at Dr. Wahidin Sudirohusodo Public Hospital was performed comprising b-hCG levels of hydatiform mole
patients before and after curettage. b-hCG level (Elisa's method) were grouped by age of pregnancy. Among 72 patients, 43 patients with
hydatiform mole were found. At trimester I among 10 patients (23.3%), b-hCG level was higher 3 (7.0%), normally 4 (9.3%) and lower
3 (7.0%). At trimester II, among 33 patients (76.7%), b-hCG level was higher 12 (27.9%), normal 13 (30.2%) and lower 3 (7.0%).
After curretage, b-hCG level was decreased in 35 (81.4%), and increased in 7 (16.3%). Diagnosis of hydatiform mole was established
in 36 (83.7%) and Gestational Trophoblastic Tumours (GTT) 7 (16.3%). Patients with hydatiform mole had the highest incidence in
trimester II with normal b-hCG level and b-hCG level decreased after curretage.